11th May 2006 10:15
AGI Therapeutics plc11 May 2006 AGI Therapeutics plc ('AGI' or the 'Company') Award of Options Following his appointment as Director and Chief Financial Officer, AGI hasawarded David Kelly options over 505,596 ordinary shares of €0.01 each in theshare capital of the Company in accordance with the Company's share optionscheme and with an exercise price of €1.47. 11 May, 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai